Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia
Stefania Fiorcari, Silvia Martinelli, Jenny Bulgarelli, et al.
Haematologica (2014) Vol. 100, Iss. 2, pp. 253-262
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
Valentina Audrito, Sara Serra, Davide Brusa, et al.
Blood (2014) Vol. 125, Iss. 1, pp. 111-123
Open Access | Times Cited: 166
Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds
Kathryn Lagrue, Alexandre F. Carisey, David J. Morgan, et al.
Blood (2015) Vol. 126, Iss. 1, pp. 50-60
Open Access | Times Cited: 119
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
Stefania Fiorcari, Rossana Maffei, Valentina Audrito, et al.
Oncotarget (2016) Vol. 7, Iss. 40, pp. 65968-65981
Open Access | Times Cited: 96
Role of the tumor microenvironment in mature B-cell lymphoid malignancies
Nathan Fowler, Chan Y. Cheah, Randy D. Gascoyne, et al.
Haematologica (2016) Vol. 101, Iss. 5, pp. 531-540
Open Access | Times Cited: 93
The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
Mirjeta Qorraj, Heiko Bruns, Martin Böttcher, et al.
Leukemia (2016) Vol. 31, Iss. 2, pp. 470-478
Closed Access | Times Cited: 93
Topical cell-free conditioned media harvested from adipose tissue-derived stem cells promote recovery from corneal epithelial defects caused by chemical burns
Gae Won Park, Jeonghoon Heo, Jung Youb Kang, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 83
Targeting the tumor microenvironment in chronic lymphocytic leukemia
Rebecca Svanberg Teglgaard, Sine Janum, Piers Patten, et al.
Haematologica (2021) Vol. 106, Iss. 9, pp. 2312-2324
Open Access | Times Cited: 62
The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia
Erica Dander, Chiara Palmi, Giovanna D’Amico, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4426-4426
Open Access | Times Cited: 50
The Role of Tumor-Associated Macrophages in Hematologic Malignancies
Emanuele Cencini, Alberto Fabbri, Anna Sicuranza, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3597-3597
Open Access | Times Cited: 44
Macrophage Polarization Reflects T Cell Composition of Tumor Microenvironment in Pediatric Classical Hodgkin Lymphoma and Has Impact on Survival
Mário Henrique M. Barros, Priscilla Segges, Gabriela Vera‐Lozada, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0124531-e0124531
Open Access | Times Cited: 61
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib
Rossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Journal of Hematology & Oncology (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Shaping of the tumor microenvironment: Stromal cells and vessels
Marzenna Blonska, Nitin Agarwal, Francisco Vega
Seminars in Cancer Biology (2015) Vol. 34, pp. 3-13
Open Access | Times Cited: 47
The Role of Tumor-Associated Macrophages in Leukemia
Yueyang Li, M. James You, Ya‐Ling Yang, et al.
Acta Haematologica (2019) Vol. 143, Iss. 2, pp. 112-117
Open Access | Times Cited: 39
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments
Stefania Fiorcari, Rossana Maffei, Claudio Giacinto Atene, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 217-217
Open Access | Times Cited: 28
Lenalidomide in the treatment of chronic lymphocytic leukemia
Gilad Itchaki, Jennifer R. Brown
Expert Opinion on Investigational Drugs (2017) Vol. 26, Iss. 5, pp. 633-650
Closed Access | Times Cited: 37
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia
Sarah Tettamanti, Maria Caterina Rotiroti, Greta Maria Paola Giordano Attianese, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 7, pp. 1566-1579
Open Access | Times Cited: 17
Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia
Richard Lewis, Alexander F. vom Stein, Michael Hallek
Blood (2024) Vol. 144, Iss. 6, pp. 601-614
Open Access | Times Cited: 3
Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia
Bola S. Hanna, Selcen Öztürk, Martina Seiffert
Molecular Immunology (2017) Vol. 110, pp. 77-87
Closed Access | Times Cited: 32
The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide
Hila Shaim, Zeev Estrov, David Harris, et al.
Frontiers in Immunology (2018) Vol. 8
Open Access | Times Cited: 30
RETRACTED ARTICLE: Downregulated lncRNA CRNDE contributes to the enhancement of nerve repair after traumatic brain injury in rats
Min Yi, Xingping Dai, Qiuxia Li, et al.
Cell Cycle (2019) Vol. 18, Iss. 18, pp. 2332-2343
Open Access | Times Cited: 29
Rhesus θ-defensin-1 (RTD-1) exhibitsin vitroandin vivoactivity against cystic fibrosis strains ofPseudomonas aeruginosa
Paul M. Beringer, Timothy J. Bensman, Henry C. Ho, et al.
Journal of Antimicrobial Chemotherapy (2015) Vol. 71, Iss. 1, pp. 181-188
Open Access | Times Cited: 25
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Xavier Leleu, Francesca Gay, Anne Flament, et al.
Annals of Hematology (2017) Vol. 97, Iss. 3, pp. 387-400
Open Access | Times Cited: 25
Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies
Yutong Xie, Huan Yang, Chao Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms
Hao Guo, Jingyi Yang, Haoran Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs
Ota Fuchs
Cardiovascular & Haematological Disorders - Drug Targets (2018) Vol. 19, Iss. 1, pp. 51-78
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top